IgG Drug Delivery via the airways – focus on inhalative and intranasal application

From the treatment of local diseases to innovative approaches in the therapy of brain disorders – the respiratory tract presents a promising but complex site of application for non- to minimally invasive delivery of IgG antibodies. Our invited speakers from industry and academia will discuss about their different approaches, challenges and successes stories. The conference will be hosted by Dana Hofmann known from TV (ZDF).

Confirmed speakers and talks are:

Prof. Dr. Nathalie Heuzé-Vourc’h, Research Center for Respiratory Diseases, Tours (France):
Oral inhalation of monoclonal antibodies:  what are the next steps!

Dr. Anna Schnell, CSL Behring AG (Switzerland):
Topical Application of Nebulized Polyclonal IgG:
from Proof of Concept in to the Clinical Development

Dr. Emre Türeli, MyBiotech GmbH (Germany):
Extended release nanoparticles for intranasal and inhalative applications

Dr. Otmar Schmid, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (Germany):
Bringing aerosols to preclinical testing of inhaled drugs

Dr. Simone Ladel, Wirtschaftsgenossenschaft deutscher Tierärzte eG/ University of Applied Sciences Biberach (Germany):
Fc receptor-mediated uptake of IgGs in airway mucosa

Prof. Dr. Katharina Schindowski Zimmermann, University of Applied Sciences Biberach (Germany):
proof of concept studies for intranasal nose-to-brain delivery in mini pigs

You are invited to join our conference on September 22nd 2022 live at Biberach University in Biberach Riss (Germany) or online via MS Teams.
More information and a detailed program will follow. Registration opens soon.
For further questions, please contact us via drug-delivery@hochschule-bc.de. For directions to Biberach see https://www.hochschule-biberach.de/anreise-und-lageplaene.
We are looking forward to welcome you in Biberach or online via MS Teams. The event is free, registration is required via https://innosued.de/idea2022.